Novavax Inc (NVAX) Stock Price, Quote & News

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the...

Industry: Biotechnology

Sector: Healthcare

Phone: 240 268 2000

Website: www.novavax.com

Address:

21 Firstfield Road, Gaithersburg, United States

longshort168 Jun. 25 at 2:52 PM

$NVAX Why pump this shit POS? W/O short covering, the SP won't go anywhere and the a-hole JJ careless about shareholders value but his stolen 10M$ annual package

0 · Reply

upgrayeddd Jun. 25 at 2:51 PM

$NVAX flush out the COVID dorks! Make room for real investors that get the new strategy! Capitulate!

1 · Reply

Antioch_Capital Jun. 25 at 2:31 PM

$NVAX The poor, the frustrated. Completely understandable. I was frustrated too. There’s always collecting Pokémon cards or coins with the gauche logos on them if this doesn’t work out for you. The transformation is near, but it ain’t here.

0 · Reply

Ctizzle Jun. 25 at 2:31 PM

$NVAX "Creating tomorrows shareholder value, today!"

1 · Reply

ddirk Jun. 25 at 2:31 PM

$NVAX does this look like today….NO just empty promises

0 · Reply

nikeita Jun. 25 at 2:26 PM

$NVAX Zero shares to borrow?

1 · Reply

McKenzo Jun. 25 at 2:23 PM

$NVAX Even a quick PR noting a close vote and thanking shareholders who supported their ongoing efforts - affirming a commitment - recognizing that there is a large block of shareholders who are unhappy would be nice. Simply etiquette dictates saying thank you after getting a generous gift.

1 · Reply

Benroxx Jun. 25 at 2:22 PM

$NVAX What is this shit? I am I gonna die tryin??

0 · Reply

CIOBRAN Jun. 25 at 2:18 PM

$NVAX GET OUT OF HERE QUICKLY YOU IDIOT, DON'T LET ME SEE YOU AGAIN AND GO EAT A NICE ICE CREAM FULL OF SHIT AND DIGEST IT WELL, PLEASE, YOU BIG IDIOT!

0 · Reply

ddirk Jun. 25 at 2:08 PM

$NVAX your chart this morning is a nice story- but false, what your posting now is empty promises. Starting to sound like Trump when he talked about lowering price

1 · Reply

Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM

2026-06-22T15:15:08.000Z - 2 days ago

Novavax put volume heavy and directionally bearish

Jun 18, 2026, 8:30 AM EDT - 7 days ago

Novavax Transcript: AGM 2026

Jun 4, 2026, 10:30 AM EDT - 21 days ago

Novavax Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 4:00 PM EDT - 23 days ago

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

May 13, 2026, 6:40 PM EDT - 6 weeks ago

Novavax Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 7:00 AM EDT - 6 weeks ago

Novavax Slides: Corporate presentation

May 11, 2026, 7:53 AM EDT - 6 weeks ago

Hantavirus cases spark surge in pharma and biotech stocks — here's why

EBS INO MRNA

May 7, 2026, 4:00 PM EDT - 6 weeks ago

Novavax to Participate in BofA Securities 2026 Health Care Conference

2026-05-07T06:32:47.000Z - 7 weeks ago

Novavax reports Q1 EPS (6c), consensus (23c)

2026-05-07T05:08:24.000Z - 7 weeks ago

Novavax price target raised to $9 from $8 at TD Cowen

SNY

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Novavax Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Novavax Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Novavax Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Novavax Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

May 6, 2026, 7:56 AM EDT - 7 weeks ago

Novavax beats first-quarter revenue estimates on vaccine deals strength

Apr 29, 2026, 4:00 PM EDT - 2 months ago

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Novavax Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Novavax Proxy statement: Proxy filing

2026-04-09T14:00:15.000Z - 2 months ago

Novavax price target raised to $18 from $16 at B. Riley

Apr 8, 2026, 6:08 AM EDT - 2 months ago

Shah Capital intends to vote against Novavax's board nominees, executive compensation

Mar 30, 2026, 8:00 AM EDT - 3 months ago

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

Mar 10, 2026, 3:40 PM EDT - 3 months ago

Novavax Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 2:30 PM EST - 4 months ago

Novavax Transcript: TD Cowen 46th Annual Health Care Conference

2026-02-27T15:25:36.000Z - 4 months ago

Novavax price target raised to $8 from $7 at BofA

Feb 26, 2026, 4:30 PM EST - 4 months ago

Novavax to Participate in Upcoming Investor Conferences

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Slides: Q4 2025

Feb 26, 2026, 8:06 AM EST - 4 months ago

Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals

Feb 26, 2026, 8:00 AM EST - 4 months ago

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Feb 19, 2026, 8:00 AM EST - 4 months ago

Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Jan 20, 2026, 7:15 AM EST - 5 months ago

Novavax Announces Entering into a License Agreement with Pfizer

Jan 20, 2026, 7:11 AM EST - 5 months ago

Novavax enters license agreement with Pfizer for vaccine development

PFE

Jan 14, 2026, 7:30 PM EST - 5 months ago

Novavax Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:30 PM EST - 5 months ago

Novavax Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 6 months ago

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 1, 2025, 3:50 PM EST - 7 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA PFE

Dec 1, 2025, 12:35 PM EST - 7 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA PFE

Dec 1, 2025, 9:59 AM EST - 7 months ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

MRNA

Nov 19, 2025, 11:30 AM EST - 7 months ago

Novavax Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 4:41 PM EST - 8 months ago

Shah Capital pushes for Novavax sale, warns of proxy fight

Nov 12, 2025, 8:00 AM EST - 8 months ago

Novavax to Participate in Jefferies London Healthcare Conference

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 6, 2025, 7:58 AM EST - 8 months ago

Novavax raises annual revenue forecast on strength of vaccine deals

Nov 4, 2025, 7:00 AM EST - 8 months ago

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Oct 30, 2025, 8:00 AM EDT - 8 months ago

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 22, 2025, 7:00 AM EDT - 8 months ago

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Oct 14, 2025, 6:09 AM EDT - 9 months ago

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Oct 7, 2025, 7:00 AM EDT - 9 months ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Sep 30, 2025, 9:01 AM EDT - 9 months ago

Novavax Announces Progress on Sanofi Agreement

Sep 19, 2025, 11:40 AM EDT - 9 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

BNTX MRNA PFE

Sep 4, 2025, 10:20 AM EDT - 10 months ago

Novavax Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 8:00 AM EDT - 10 months ago

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Sep 3, 2025, 8:00 AM EDT - 10 months ago

Novavax to Participate in the Cantor Global Healthcare Conference

Aug 27, 2025, 3:07 PM EDT - 10 months ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Aug 21, 2025, 7:43 AM EDT - 11 months ago

Novavax Announces Convertible Debt Refinancing

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Novavax Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Novavax Earnings release: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Novavax Quarterly report: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Novavax Slides: Q2 2025

Aug 6, 2025, 8:08 AM EDT - 11 months ago

Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:00 AM EDT - 11 months ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Jul 30, 2025, 8:00 AM EDT - 11 months ago

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Novavax Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Novavax Slides: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 7:11 AM EDT - 1 year ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:00 AM EDT - 1 year ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 10, 2025, 10:45 AM EDT - 1 year ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Jun 10, 2025, 9:30 AM EDT - 1 year ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Jun 10, 2025, 8:18 AM EDT - 1 year ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

May 20, 2025, 4:34 PM EDT - 1 year ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 19, 2025, 12:15 PM EDT - 1 year ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

May 19, 2025, 9:27 AM EDT - 1 year ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 7:16 AM EDT - 1 year ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

May 19, 2025, 7:00 AM EDT - 1 year ago

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

May 17, 2025, 10:26 PM EDT - 1 year ago

FDA approves Novavax COVID vaccine with new conditions

May 14, 2025, 6:00 PM EDT - 1 year ago

Novavax Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 6:00 PM EDT - 1 year ago

Novavax Slides: FY 2025

May 8, 2025, 11:12 AM EDT - 1 year ago

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

longshort168 Jun. 25 at 2:52 PM

$NVAX Why pump this shit POS? W/O short covering, the SP won't go anywhere and the a-hole JJ careless about shareholders value but his stolen 10M$ annual package

0 · Reply

upgrayeddd Jun. 25 at 2:51 PM

$NVAX flush out the COVID dorks! Make room for real investors that get the new strategy! Capitulate!

1 · Reply

Antioch_Capital Jun. 25 at 2:31 PM

0 · Reply

Ctizzle Jun. 25 at 2:31 PM

$NVAX "Creating tomorrows shareholder value, today!"

1 · Reply

ddirk Jun. 25 at 2:31 PM

$NVAX does this look like today….NO just empty promises

0 · Reply

nikeita Jun. 25 at 2:26 PM

$NVAX Zero shares to borrow?

1 · Reply

McKenzo Jun. 25 at 2:23 PM

1 · Reply

Benroxx Jun. 25 at 2:22 PM

$NVAX What is this shit? I am I gonna die tryin??

0 · Reply

CIOBRAN Jun. 25 at 2:18 PM

$NVAX GET OUT OF HERE QUICKLY YOU IDIOT, DON'T LET ME SEE YOU AGAIN AND GO EAT A NICE ICE CREAM FULL OF SHIT AND DIGEST IT WELL, PLEASE, YOU BIG IDIOT!

0 · Reply

ddirk Jun. 25 at 2:08 PM

$NVAX your chart this morning is a nice story- but false, what your posting now is empty promises. Starting to sound like Trump when he talked about lowering price

1 · Reply

Joenotdaman Jun. 25 at 2:07 PM

$NVAX = Dead Stock

0 · Reply

Trader00995 Jun. 25 at 2:06 PM

$NVAX 🤣

0 · Reply

Antioch_Capital Jun. 25 at 2:06 PM

$NVAX Thumbs down, TWO sad face emojis, PU, stinky stinky. 🤮 I’ll let you guys hold those 50-300 shares and I’ll come back years later when the company is fully transformed for a new long position before takeoff under 8. See you soon!

1 · Reply

DarvasBoxing Jun. 25 at 2:03 PM

$NVAX didn’t expect to catch some limit shares today.

2 · Reply

Hoodoo_Voodoo Jun. 25 at 2:01 PM

$NVAX XBI only thing green and this is still red 😂

0 · Reply

La_Parka3 Jun. 25 at 1:58 PM

$NVAX The market's all red but still, whiners are whining about JJ today.

2 · Reply

dkallday Jun. 25 at 1:53 PM

$NVAX F u novavax

0 · Reply

BTC321 Jun. 25 at 1:50 PM

$NVAX There's just one chant during world cup: FCK YOU JJ! FCK YOU JJ! FCK YOU JJ!!!!!!!!!!!!!!

0 · Reply

ChannelGuru Jun. 25 at 1:47 PM

$NVAX Nothing to see here until August Earnings report. Dont waste your time. This board is boring as JJ stopped sharing any information. Go and enjoy your summer and the World Cup. PS There is only one World cup and its in your back yard !

2 · Reply

WhosYourDaddy_ Jun. 25 at 1:44 PM

$NVAX that's the only high you're getting

1 · Reply

dkallday Jun. 25 at 1:43 PM

$NVAX Oncology is coming when they decide it.

0 · Reply

WhosYourDaddy_ Jun. 25 at 1:43 PM

$NVAX who else is watching that j j?Special

0 · Reply

Market Cap	1.48B
Revenue (ttm)	1.12B
Net Income (ttm)	440.30M
EPS (ttm)	N/A
PE Ratio	182.60
Forward PE	N/A
Profit Margin	39.19%
Debt to Equity Ratio	-2.01

Volume	3,507,600
Avg Vol	4,934,694
Day's Range	N/A - N/A
Shares Out	164.44M
Stochastic %K	29%
Beta	2.45
Analysts	Sell
Price Target	$14.11